Indication
Merkel cell carcinoma
Merkel cell carcinoma is a rare, aggressive neuroendocrine malignancy of the skin that arises within the basal layer of the epidermis and the dermis. Read more about Merkel cell carcinoma
5 drugs 3 manufacturers
Drugs that treat it
Common Merkel cell carcinoma therapies.
KEYTRUDA (pembrolizumab)
BAVENCIO (avelumab)
ZYNYZ (retifanlimab-dlwr)
KEYTRUDA QLEX (pembrolizumab-berahyaluronidase alfa-pmph)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMerkel cell carcinoma is a rare, aggressive neuroendocrine malignancy of the skin that arises within the basal layer of the epidermis and the dermis.
It predominantly affects older adults, fair-skinned individuals, and immunocompromised populations, most commonly developing on chronically sun-exposed areas such as the head, neck, and extremities.
Clinically, it typically presents as a rapidly growing, painless, firm, flesh-colored to violaceous cutaneous or subcutaneous nodule.
Pathophysiologically, oncogenesis is strongly driven either by integration of the Merkel cell polyomavirus or by extensive ultraviolet radiation–induced somatic DNA damage, both pathways conferring high rates of local recurrence and early regional or distant metastasis.
- cancer.gov
Merkel cell carcinoma is a rare, aggressive neuroendocrine malignancy of the skin that arises within the basal layer of the epidermis and the dermis
- nih.gov
Merkel cell carcinoma is a rare, aggressive neuroendocrine malignancy of the skin that arises within the basal layer of the epidermis and the dermis It predominantly affects older adults, fair-skinned individuals, and immunocompromised populations, most commonly developing on chronically sun-exposed areas such as the head, neck, and extremities Pathophysiologically, oncogenesis is strongly driven either by integration of the Merkel cell polyomavirus or by extensive ultraviolet radiation–induced ...
- nih.gov
It predominantly affects older adults, fair-skinned individuals, and immunocompromised populations, most commonly developing on chronically sun-exposed areas such as the head, neck, and extremities Clinically, it typically presents as a rapidly growing, painless, firm, flesh-colored to violaceous cutaneous or subcutaneous nodule Pathophysiologically, oncogenesis is strongly driven either by integration of the Merkel cell polyomavirus or by extensive ultraviolet radiation–induced somatic DNA dama...
- nih.gov
Clinically, it typically presents as a rapidly growing, painless, firm, flesh-colored to violaceous cutaneous or subcutaneous nodule
- nih.gov
Pathophysiologically, oncogenesis is strongly driven either by integration of the Merkel cell polyomavirus or by extensive ultraviolet radiation–induced somatic DNA damage, both pathways conferring high rates of local recurrence and early regional or distant metastasis
Personalize your experience
Follow Merkel cell carcinoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.